+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Third-party Pathology Diagnosis Center Market - Global Forecast 2026-2032- Product Image
Third-party Pathology Diagnosis Center Market - Global Forecast 2026-2032- Product Image
New

Third-party Pathology Diagnosis Center Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081035
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The third-party pathology diagnosis center market is entering a period of sustained transformation, characterized by rising clinical complexity, digitization, and a stronger focus on operational resilience. Senior leaders face intensifying pressure to select partners who can deliver both specialized expertise and measurable operational performance.

Market Snapshot: Third-party Pathology Diagnosis Center Market

The third-party pathology diagnosis center market grew from USD 2.30 billion in 2025 to USD 2.49 billion in 2026. It is expected to continue growing at a CAGR of 10.12%, reaching USD 4.52 billion by 2032.

Scope & Segmentation

  • Service Types: Routine histopathology, subspecialty interpretations, integrated diagnostic reporting, immunohistochemistry, and molecular pathology.
  • End-user Segments: Hospitals and health systems, outpatient clinics, ambulatory surgery centers, research organizations, and biopharma partners.
  • Technology Deployment: Digital pathology, whole-slide imaging, laboratory automation, artificial intelligence (AI), informatics integration, and secure data workflows.
  • Geographies Covered: Americas, Europe, Middle East & Africa, Asia-Pacific.
  • Operational Models: Independent centers, networked providers, partnership-driven labs, regional alliances.

Key Takeaways for Senior Decision-Makers

  • The role of third-party pathology diagnosis centers has shifted from overflow providers to core partners for health systems that require speed, operational efficiency, and scalable specialization.
  • Digital transformation, including the migration to whole-slide imaging and workflow-embedded AI, is reshaping service delivery and creating new pathways for remote consultation, subspecialty access, and error reduction.
  • Organizations increasingly differentiate through depth of subspecialty expertise, standardized quality management systems, and the ability to deliver audit-ready outcomes across multi-site networks.
  • Clinical and payer-driven demands for consistency, transparency in AI governance, and documented quality metrics are tightening commercial and regulatory accountability throughout the diagnostic chain.
  • Regional variation drives unique requirements: The Americas emphasize interoperability and digital access; Western Europe focuses on quality standards; emerging regions underscore logistics, training, and local capacity-building.
  • Leading centers use digital infrastructure and consultative services to create value for hospitals and research partners—embedding themselves deeper into care pathways.

Tariff Impact on Sourcing and Operations

United States tariff actions are directly influencing procurement and operational strategies for third-party pathology centers. Many depend on globally sourced reagents, consumables, and automation components, increasing cost and availability volatility. To address this, leaders are prioritizing resilient supply chains, qualifying alternatives, and redefining contract language to manage trade risks and continuity of operations. Tariff pressures are also influencing capital planning, encouraging centers to extend equipment life or invest in software-led productivity improvements.

Methodology & Data Sources

This report integrates structured secondary research with stakeholder interviews to provide a comprehensive view of the third-party pathology diagnosis center market. Sources include regulatory documentation, procurement frameworks, industry publications, and primary input from laboratory leaders, procurement specialists, and technology executives, ensuring a decision-grade evidence base.

Why This Report Matters

  • Enables executives to benchmark operational models, technology adoption, and risk management strategies against the evolving expectations of healthcare buyers.
  • Offers segment-specific insights that inform investment, procurement, and partnership selection across diverse regions and technology environments.
  • Equips leadership with actionable intelligence to adapt to tariff-driven volatility, regulatory change, and increasing demand for audit-ready clinical performance.

Conclusion

The third-party pathology diagnosis center market is being redefined by digital execution, resilient operations, and consultative clinical partnership. Organizations that invest in quality systems, risk-managed sourcing, and technology-enabled workflows will remain strong partners through dynamic market shifts.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Third-party Pathology Diagnosis Center Market, by Service Type
8.1. Anatomic Pathology
8.2. Clinical Pathology
8.3. Cytogenetics
8.4. Microbiology
8.5. Molecular Pathology
8.5.1. Fluorescence In Situ Hybridization
8.5.2. Next Generation Sequencing
8.5.2.1. Targeted Next Generation Sequencing
8.5.2.2. Whole Exome Sequencing
8.5.2.3. Whole Genome Sequencing
8.5.3. Polymerase Chain Reaction
9. Third-party Pathology Diagnosis Center Market, by Technology
9.1. Digital Pathology
9.2. Flow Cytometry
9.3. Immunohistochemistry
9.4. Next Generation Sequencing
10. Third-party Pathology Diagnosis Center Market, by Sample Type
10.1. Blood
10.2. Tissue
10.3. Urine
11. Third-party Pathology Diagnosis Center Market, by Delivery Mode
11.1. Inhouse
11.2. Outsourced
12. Third-party Pathology Diagnosis Center Market, by Application
12.1. Cardiology
12.2. Gastroenterology
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology
13. Third-party Pathology Diagnosis Center Market, by End User
13.1. Academic & Research Institutes
13.2. Clinics
13.3. Diagnostic Laboratories
13.4. Hospitals
14. Third-party Pathology Diagnosis Center Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Third-party Pathology Diagnosis Center Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Third-party Pathology Diagnosis Center Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Third-party Pathology Diagnosis Center Market
18. China Third-party Pathology Diagnosis Center Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Apollo Health and Lifestyle Limited
19.6. ARUP Laboratories, Inc.
19.7. BioReference Laboratories, Inc.
19.8. Cerba Research SAS / Cerba Healthcare
19.9. Charles River Laboratories International, Inc.
19.10. Dr. Lal PathLabs Limited
19.11. Eurofins Scientific SE
19.12. ICON Public Limited Company (ICON plc)
19.13. Laboratory Corporation of America Holdings
19.14. Mayo Clinic Laboratories
19.15. Metropolis Healthcare Limited
19.16. Quest Diagnostics Incorporated
19.17. Sonic Healthcare Limited
19.18. Thyrocare Technologies Limited
19.19. Vijaya Diagnostic Centre Private Limited
List of Figures
FIGURE 1. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 138. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 154. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 155. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 156. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 158. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 174. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 175. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASEAN THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 183. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 184. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 187. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. GCC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 201. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 202. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 204. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 205. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. BRICS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 210. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 211. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 214. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. G7 THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 219. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 220. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 222. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 223. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. NATO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 237. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 238. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 239. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 241. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 242. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. CHINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Third-party Pathology Diagnosis Center market report include:
  • Apollo Health and Lifestyle Limited
  • ARUP Laboratories, Inc.
  • BioReference Laboratories, Inc.
  • Cerba Research SAS / Cerba Healthcare
  • Charles River Laboratories International, Inc.
  • Dr. Lal PathLabs Limited
  • Eurofins Scientific SE
  • ICON Public Limited Company (ICON plc)
  • Laboratory Corporation of America Holdings
  • Mayo Clinic Laboratories
  • Metropolis Healthcare Limited
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Thyrocare Technologies Limited
  • Vijaya Diagnostic Centre Private Limited

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.52 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Third-party Medical Institutions Market - Global Forecast 2026-2032 - Product Image

Third-party Medical Institutions Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032 - Product Image

Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032

  • Report
  • 352 Pages
  • Global
From
Artificial Intelligence in Healthcare Diagnosis Market Report 2025 - Product Image

Artificial Intelligence in Healthcare Diagnosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Medical Transcription Outsourcing Service Market - Global Forecast 2025-2030 - Product Image

Medical Transcription Outsourcing Service Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Artificial Intelligence in Healthcare Diagnosis Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Artificial Intelligence in Healthcare Diagnosis Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.